Core Viewpoint - The stock of Kefu Medical (301087) has shown a slight increase, with a closing price of 41.63 yuan on November 25, 2025, reflecting a 0.65% rise, amidst mixed capital flows from different investor types [1]. Group 1: Stock Performance and Capital Flow - On November 25, 2025, Kefu Medical's stock recorded a trading volume of 12,800 hands and a transaction amount of 53.37 million yuan [1]. - The net inflow of main funds was 404,900 yuan, accounting for 0.76% of the total transaction amount, while retail investors saw a net inflow of 878,500 yuan, representing 1.65% [1]. - Over the past five days, the stock has experienced fluctuations in capital flow, with notable net outflows from main funds on several days [1]. Group 2: Company Financial Metrics - Kefu Medical's total market value is 8.696 billion yuan, with a net asset value of 4.75 billion yuan and a net profit of 260 million yuan [2]. - The company has a price-to-earnings ratio of 25.06 and a price-to-book ratio of 1.84, both of which are favorable compared to industry averages [2]. - For the first three quarters of 2025, Kefu Medical reported a main revenue of 2.398 billion yuan, a year-on-year increase of 6.63%, and a net profit of 260 million yuan, up 3.3% year-on-year [2]. Group 3: Institutional Ratings - In the last 90 days, eight institutions have rated Kefu Medical with a "buy" recommendation, indicating strong confidence in the stock [3]. - The average target price set by institutions for Kefu Medical over the past 90 days is 53.84 yuan [3].
股票行情快报：可孚医疗（301087）11月25日主力资金净买入40.49万元